Mechanisms of Dupilumab

被引：342

作者：

Harb, Hani ^{[1
]}

Chatila, Talal A. ^{[1
]}

机构：

[1] Harvard Med Sch, Boston Childrens Hosp, Div Immunol, Dept Pediat, Boston, MA 02115 USA

来源：

CLINICAL AND EXPERIMENTAL ALLERGY | 2020年 / 50卷 / 01期

关键词：

asthma; atopic dermatitis; dupilumab; food allergy; IL-4R; T cells; T-reg; INNATE LYMPHOID-CELLS; SEVERE ATOPIC-DERMATITIS; RECEPTOR-ALPHA CHAIN; REGULATORY T-CELLS; IL-4; RECEPTOR; CHRONIC RHINOSINUSITIS; AIRWAY INFLAMMATION; SIGNAL-TRANSDUCTION; MICE LACKING; INTERLEUKIN-4;

D O I：

10.1111/cea.13491

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

The Th2 cytokines interleukin 4 (IL-4) and IL-13 and the heterodimeric IL-4 receptor (IL-4R) complexes that they interact with play a key role in the pathogenesis of allergic disorders. Dupilumab is a humanized IgG4 monoclonal antibody that targets the IL-4 receptor alpha chain (IL-4R alpha), common to both IL-4R complexes: type 1 (IL-4R alpha/gamma c; IL-4 specific) and type 2 (IL-4R alpha/IL-13R alpha 1; IL-4 and IL-13 specific). In this review, we detail the current state of knowledge of the different signalling pathways coupled to the IL-4R complexes and examine the possible mechanisms of Dupilumab action and survey its clinical efficacy in different allergic disorders. The development of Dupilumab and the widening spectrum of its clinical applications is relevant to the current emphasis on precision medicine approaches to the blockade of pathways involved in allergic diseases.

引用

页码：5 / 14

页数：10

共 95 条

[1] Oral immunotherapy with omalizumab reverses the Th2 cell-like programme of regulatory T cells and restores their function [J].

Abdel-Gadir, A. ;

Schneider, L. ;

Casini, A. ;

Charbonnier, L. -M. ;

Little, S. V. ;

Harrington, T. ;

Umetsu, D. T. ;

Rachid, R. ;

Chatila, T. A. .

CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (07) :825-836

[2] The double-edged role of 12/15-lipoxygenase during inflammation and immunity [J].

Ackermann, Jochen A. ;

Hofheinz, Katharina ;

Zaiss, Mario M. ;

Kroenke, Gerhard .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2017, 1862 (04) :371-381

[3] IL-4 is more effective than IL-13 for in vitro differentiation of dendritic cells from peripheral blood mononuclear cells [J].

Ahn, JS ;

Agrawal, B .

INTERNATIONAL IMMUNOLOGY, 2005, 17 (10) :1337-1346

[4] Conjunctivitis in dupilumab clinical trials [J].

Akinlade, B. ;

Guttman-Yassky, E. ;

de Bruin-Weller, M. ;

Simpson, E. L. ;

Blauvelt, A. ;

Cork, M. J. ;

Prens, E. ;

Asbell, P. ;

Akpek, E. ;

Corren, J. ;

Bachert, C. ;

Hirano, I. ;

Weyne, J. ;

Korotzer, A. ;

Chen, Z. ;

Hultsch, T. ;

Zhu, X. ;

Davis, J. D. ;

Mannent, L. ;

Hamilton, J. D. ;

Teper, A. ;

Staudinger, H. ;

Rizova, E. ;

Pirozzi, G. ;

Graham, N. M. H. ;

Shumel, B. ;

Ardeleanu, M. ;

Wollenberg, A. .

BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (03) :459-473

[5] The emerging biologic therapies on food allergy [J].

Albuhairi, Sultan ;

Rachid, Rima .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 122 (06) :556-558

[6]

Ana Kostic LK, 2016, METHODS TREATING EOS

[7]

[Anonymous], 2018, STUD PED SUBJ PEAN A

[8]

[Anonymous], 2019, ALLERGY

[9] The Foxp3+ regulatory T-cell population requires IL-4Rα signaling to control inflammation during helminth infections [J].

Aziz, Nada Abdel ;

Nono, Justin Komguep ;

Mpotje, Thabo ;

Brombacher, Frank .

PLOS BIOLOGY, 2018, 16 (10)

[10] Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma [J].

Bachert, Claus ;

Hellings, Peter W. ;

Mullol, Joaquim ;

Naclerio, Robert M. ;

Chao, Jingdong ;

Amin, Nikhil ;

Grabher, Annette ;

Swanson, Brian N. ;

Hamilton, Jennifer D. ;

Guillonneau, Sophie ;

Tanioui, Christine ;

Zhang, Donghui ;

Pirozzi, Gianluca ;

Graham, Neil M. H. ;

Staudinger, Heribert ;

Mannent, Leda P. ;

Khan, Asif .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (07) :2447-+

← 1 2 3 4 5 6 7 8 9 10 →